BIANCA CARROLL: Open Payments
NPI 1649658030 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 9 payments from 9 companies in 2025. Trend: 2023 $882 · 2024 $989 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Exeltis, USA Inc. | 1 | $125 |
| Amgen Inc. | 1 | $115 |
| Astellas Pharma US Inc | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 1 | $95 |
| REVANCE THERAPEUTICS, INC. | 1 | $70 |
| ABBVIE INC. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
Products named: Korlym, ENTYVIO, Veozah, BREZTRI, DAXXIFY, VRAYLAR, VIVITROL.
Industry payments across FL — which companies pay providers there.
